{
    "nctId": "NCT05893368",
    "briefTitle": "New Model for Integrating Person-based Care (PbC) in the Treatment of Advanced HER2-negative Breast Cancer",
    "officialTitle": "New Model for Integrating Person-based Care (PbC) in the Treatment of Advanced HER2-negative Breast Cancer: InPerson Study",
    "overallStatus": "RECRUITING",
    "conditions": "Advanced Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Standardized quality of life measurement",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient able to understand, sign and date the informed consent prior to any specific study procedure;\n* Diagnosis of HER2-negative advanced breast cancer (ER and PgR hormone receptor negative or ER and/or PgR receptor positive), undergoing cancer treatment\n* Age \u226518 years\n* Knowledge of the Italian language\n* Life expectancy \u2265 24 weeks\n* Basic level of digital knowledge.\n\nExclusion Criteria:\n\n* Inability to participate in the patient's study (psychiatric disorders, PS ECOG \\> 2) and unavailability of caregiver;\n* Unavailability of an e-mail account or unavailability to use web-based tools (for the patient/caregiver);\n* Patients who do not sign informed consent.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}